Power & Instrumentation (Gujarat) valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
Price multiples — at each FY-end close
1.26×————
0.12×————
0.08×————
Enterprise multiples
0.19×————
1.77×————
1.83×————
Yield
79.2%————
−32.7%————
Reference — adjusted share basis
₹88.30————
₹69.92₹68.12₹55.57₹27.86₹17.19
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PIGL₹88.30

Power & Instrumentation (Gujarat) Limited

· Capital Goods & Defence
₹ CrorePeersRMCAEPLS&SPOWERURJAPROSTARMSOLEXMEILKECLMcap ₹18.7 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E————1.26
P/B————0.12
P/Sales————0.08
Enterprise Multiples
EV/Sales————0.19
EV/EBITDA————1.77
EV/EBIT————1.83
Yield
Earnings Yield %————79.19
FCF Yield %————-32.67
Reference — adjusted share basis
Price (FY-end close, adj.)————88.30
EPS (adj.)17.1927.8655.5768.1269.92
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.